RGT — Argent BioPharma Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro CapSucker Stock

Annual balance sheet for Argent BioPharma, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.

	2022 June 30th	2023 June 30th	2024 June 30th	2025 June 30th	2026 June 30th
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Short Term Investments	1.89	0.24	0.703	1.02	0.141
Net Total Accounts Receivable
Net Total Receivables	1.94	0.531	0.477	0.376	0.239
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	6.46	2.53	2.74	2.03	0.459
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	8.8	7.45	6.72	0.438	0.102
Net Goodwill
Net Intangible Assets
Long Term Investments
Total Assets	18.6	9.98	10.8	2.47	1.29
Accounts Payable
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	7.71	13.3	12.2	10.8	8.54
Capital Lease Obligations
Total Long Term Debt
Total Debt
Minority Interest
Total Other Liabilities
Total Liabilities	12.7	17.4	15.9	11.1	10.7
Common Stock
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	5.84	-7.4	-5.15	-8.63	-9.45
Total Liabilities & Shareholders' Equity	18.6	9.98	10.8	2.47	1.29
Total Common Shares Outstanding